Find link

language:

Find link is a tool written by Edward Betts.

searching for HLA-A1 16 found (24 total)

alternate case: hLA-A1

HLA-Cw7 (216 words) [view diff] case mismatch in snippet view article find links to article

and HLA B7-DR15-DQ6 haplotypes. The class I region of these supertype is HLA A1-B8 haplotype, HLA A3-B7, HLA-A2-B7 and HLA A24-B7. Arce-Gomez B, Jones EA

HLA-DQ2 (3,380 words) [view diff] no match in snippet view article find links to article

a haplotype associated with a large number of diseases. This haplotype, HLA A1-B8-DR3-DQ2, is associated with diseases in which HLA-DQ2 has suspect involvement

HLA DR3-DQ2 (5,003 words) [view diff] no match in snippet view article find links to article

cancer, enteropathy associated T-cell lymphoma. HLA-DR3-DQ2 is found in HLA A1-B8-DR3-DQ2 haplotype in Northern Europeans (including the British Ilse,

HLA-DR10 (284 words) [view diff] exact match in snippet view article find links to article

to HLA-DQ1 and DQ5 serotypes. One haplotype found in caucasians is the HLA-A1-B37-Cw6-DR10-DQ5. derived from IMGT/HLA White A, Rostom A (1994). "HLA antigens

STK19 (631 words) [view diff] exact match in snippet view article find links to article

FT, et al. (1996). "Complete sequence of the complement C4 gene from the HLA-A1, B8, C4AQ0, C4B1, DR3 haplotype". Immunogenetics. 43 (4): 250–2. doi:10

C4A (1,679 words) [view diff] no match in snippet view article find links to article

HERV-K(C4) into intron 9. Complement component 4 Complement component 4B HLA A1-B8-DR3-DQ2 haplotype Complement system Complement deficiency ENSG00000206340

SPA17 (793 words) [view diff] exact match in snippet view article find links to article

(2004). "Identification of a sperm protein 17 CTL epitope restricted by HLA-A1". Int. J. Cancer. 107 (5): 863–5. doi:10.1002/ijc.11486. PMID 14566839.

Complement component 4B (1,049 words) [view diff] no match in snippet view article find links to article

HERV-K(C4) into intron 9. Complement component 4 Complement component 4A HLA A1-B8-DR3-DQ2 haplotype Complement system Complement deficiency ENSG00000236625

MAGEA1 (938 words) [view diff] exact match in snippet view article find links to article

overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44". J. Biol. Chem. 271 (21): 12463–71. doi:10.1074/jbc

HLA-DR (2,293 words) [view diff] no match in snippet view article find links to article

Number of Variant Alleles HLA-DR Loci HLA-DR HLA -A1 -B1 -B3 to -B51 Potential Locus # # # Combinations Alleles 3 463 74 1635 Unique Polypeptide 2 394

Complement component 4 (4,189 words) [view diff] no match in snippet view article find links to article

which the C4 partakes). Complement component 4A Complement component 4B HLA A1-B8-DR3-DQ2 haplotype Complement system Complement deficiency Sekar A, Bialas

Beta-2 microglobulin (2,117 words) [view diff] exact match in snippet view article find links to article

SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1 1w72: CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3 1x7q: Crystal structure of HLA-A*1101 with

Human leukocyte antigen (5,941 words) [view diff] no match in snippet view article find links to article

MHC class II HLA -A1 -B1 -B3 to -B51 Theor. possible locus # # # combinations DM- 7 13 91 DO- 12 13 156 DP- 67 1,014 16,036 DQ- 95 1,257 34,528 DR- 7

Cancer vaccine targeting CD4+ T cells (1,518 words) [view diff] exact match in snippet view article find links to article

HLA-DP4-restricted peptide 243–258. One patient simultaneously developed CD8+ T cells to HLA-A1-restricted peptide 168–176. The novel monitoring methodology used in this

Adoptive cell transfer (4,028 words) [view diff] exact match in snippet view article find links to article

CAR T cells specific for ERBB2. Two patients died when treated with an HLA-A1–restricted MAGE-A3–specific TCR whose affinity was enhanced by a site-specific

Cancer/testis antigens (1,967 words) [view diff] exact match in snippet view article find links to article

restriction. To date, MAGE-A3-derived peptides have been used as vaccines in HLA-A1-positive patients with tumor expressing the respective antigen. MAGE-A peptides